Substance P receptor (NK₁) gene expression in synovial tissue in rheumatoid arthritis and osteoarthritis

References

• Donald MM, James FF. An analysis of the American Rheumatism Association criteria for rheumatoid arthritis. Arthritis Rheum 1982;25:481–7.
   PubMedGoogle Scholar
• Thompson M, Bywaters EGL. Unilateral rheumatoid arthritis following hemiplegia. Ann Rheum Dis 1962;25:370–7.
   Google Scholar
• Glick EN. Asymmetrical rheumatoid arthritis after poliomyel-itis. BMJ 1967;3:26–8.
   PubMed Web of Science ®Google Scholar
• Barry W. The neurology of joints: a review of general prin-ciples. Clin Rheum Dis 1981;7:223–39.
   Google Scholar
• Tohyama M, Shiotani Y. Neuropeptides in spinal cord. Prog Brain Res 1987;66:177–218.
   Web of Science ®Google Scholar
• Pernow B. Substance P. Pharmacol Rev 1983;35:85–141.
   PubMedGoogle Scholar
• Lembeck F, Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol 1979;310:175–83.
   PubMed Web of Science ®Google Scholar
• Pernow B. Role of tachykinins in neurogenic inflammation. J Immunol 1985;135:812–5.
   PubMed Web of Science ®Google Scholar
• Garrett NE, Mapp PI, Kidd BL, Blake DR. Role of substance P in inflammatory arthritis. Ann Rheum Dis 1992;51:1014–8.
   PubMed Web of Science ®Google Scholar
• McGillis JP, Mitsuhashi M, Payan DG. Immunomodulation by tachykinin neuropeptides. Ann NY Acad Sci 1991;632:85–94.
   Google Scholar
• Pascual DW, Bost KL, Xu-Amano J, Kiyono H, McGhee JR. The cytokine-like action of substance P upon B cell differenti-ation. Reg Immunol 1992;4:100–4.
   Google Scholar
• Lembeck F, Donnerer J, Colpaert FC. Increase of substance P in primary afferent nerves during chronic pain. Neuropeptides 1981;1:175–80.
   Google Scholar
• Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basebaum Al. Intraneural substance P contributes to the severity of experimental arthritis. Science 1984;226:547–9.
   PubMed Web of Science ®Google Scholar
• Lotz M, Carson DA, Vaughan JH. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 1987;235:893–5.
   Google Scholar
• Walsh DA, Mapp PI, Wharton J, Rutherford RAD, Kidd BL, Revell PA, et al. Localization and characterization of substance P binding to human synovial tissue in rheumatoid arthritis. Ann Rheum Dis 1992;51:313–7.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arth-ritis. Arthritis Rheum 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Steinbrocker O, Traeger CG, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659–62.
   Google Scholar
• Larsen A, Dale K, Eek M. Radiographic evaluation of rheum-atoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977;18:481–91.
   Google Scholar
• Lansbury J. Quantitation of activity of rheumatoid arthritis: method for summation of systemic indices of rheumatoid activity. Am J Med Sci 1953;232:300–17.
   Google Scholar
• Bloch B, Popovici T, LE Guellec D, Normand E, Chouham S, Guitteny AF, et al. In situ hybridization histochemistry for the analysis of gene expression in the endocrine and central nervous system tissues: A 3-year experience. J Neurosci Res 1986;16:183–200.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tananka A, Hara M, Nakanishi S. The primary structure and gene organization of human substance P and neuromedin K receptors. Eur J Biochem 1992;204:1025–33.
   PubMedGoogle Scholar
• Noguchi K, Morita Y, Kiyama H, Ono K, Tohyama M. A noxious stimulus induces the preprotachykinin-A gene expres-sion in the rat dorsal root ganglion. Mol Brain Res 1988;4:31–5.
   Google Scholar
• Mapp PI, Kidd BL, Gibson SJ, Terry JM, Revell PA, Ibrahim NBN, et al. Substance P-, calcitonin gene-related peptide-, and C-flanking peptide- of neuropeptide Y-immunoreactive fibers are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 1990;37:143–53.
   PubMed Web of Science ®Google Scholar
• Gay S, Gay RE. Cellular basis and oncogene expression of rheumatoid joint destruction. Rheumatol Int 1989;9:105–13.
   PubMed Web of Science ®Google Scholar
• Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M. The c-fos protein interacts with c-Jun/AP-1 to stimulate tran-scription of AP-1 responsive genes. Cell 1988;54:541–52.
   PubMed Web of Science ®Google Scholar
• Ziff M. Role of the endothelium in chronic inflammatory synovitis. Arthritis Rheum 1991;34:1345–52.
   PubMed Web of Science ®Google Scholar
• Ziche M, Morbidelli L, Pacini M, Geppetti P, Alessandri G, Maggi CA. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 1990;40:264–78.
   PubMed Web of Science ®Google Scholar
• Ziche M, Morbidelli L, Geppetti P, Maggi CA, Dolara P. Substance P induces migration of capillary endothelial cells: A novel NK-1 selective receptor mediated activity. Life Sci 1991;48: 7–11.
   Google Scholar
• Mallya RK, de Beer FC, Berry H, Hamilton EDB, Mace BEW, Pepys MB. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentrations of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol 1982;9:224–8.
   PubMed Web of Science ®Google Scholar
• Dixon JS, Bird HA, Sitton NG, Pickup ME, Wright V. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol 1984;13:39–44.
   Google Scholar
• MCConkey B, Crockson RA, Crockson AP. The assessment of rheumatoid arthritis. Q J Med 1972;41:115–25
   Google Scholar
• Amos RS, Constable TJ, Crockson RA, Crockson AP, MCConkey B. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. BMJ 1977;1:195–7.
   Google Scholar
• Dawes PT, Fowler PD, Clarke S, Fisher J, Lawton A, Shadforth MF. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiologic progression. Br J Rheumatol 1986;25:44–9.
   PubMedGoogle Scholar
• Larsen A. The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis. Scand J Rheumatol 1988;17:123–9.
   PubMed Web of Science ®Google Scholar
• Van Leeuwen MA, Van Rijswijk MH, Van Der Heijde DMFM, TE Meerman GJ, Van Riel PLCM, Houtman PM, et al. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: A prospective study during the first three years of the disease. Br J Rheumatol 1993;32 Suppl 3:9–13.
   PubMedGoogle Scholar